Characteristics of patients with erosive and nonerosive GERD in high-helicobacter-pylori prevalence region

Size: px
Start display at page:

Download "Characteristics of patients with erosive and nonerosive GERD in high-helicobacter-pylori prevalence region"

Transcription

1 Diseases of the Esophagus (2004) 17, ISDE Blackwell Publishing, Ltd. Original article Characteristics of patients with erosive and nonerosive GERD in high-helicobacter-pylori prevalence region L. V. Jonaitis, G. Kiudelis, L. Kupcinskas Department of Gastroenterology, Kaunas University of Medicine, Kaunas, Lithuania SUMMARY. It is still not known whether there are differences between erosive and nonerosive GERD. The aim of the present study is to evaluate the prevalence of Helicobacter pylori (HP) infection, and other differences between erosive and nonerosive gastroesophageal reflux disease (NERD) patients. One-hundred and four consecutive GERD patients (mean age: 41.6 ± 12.3 years) were interviewed, endoscoped and tested for HP. Erosive GERD was defined according to the Los Angeles classification. Patients who had no erosions in the esophagus but complained of heartburn or/and acid regurgitation at least twice a week and for whom these symptoms had a negative impact on daily activities were considered to be NERD patients. Erosive GERD was identified in 53 (51%) patients (mean age: 41.0 ± 12.7 years) and NERD in 51 (49.0%) patients (mean age: 42.2 ± 11.9 years). HP infection was found in 32 (60.4%) erosive GERD patients, and 41 (80.4%) NERD patients, P < Multivariate analysis revealed that there were two statistically significant prediction factors for NERD: female sex with odds ratio (OR) of 6.34 (95% CI: ; P = ) and HP infection with odds ratio (OR) of 3.28 (95% CI: ; P = 0.015). The presence of HP and female sex are found to be statistically significant predictors of NERD. KEY WORDS: gastroesophageal reflux disease (GERD), Helicobacter pylori, nonerosive gastroesophageal reflux disease (NERD). INTRODUCTION There is a decreasing prevalence of Helicobacter pylori (HP) around the world and at the same time the incidence and prevalence of GERD increases. 1 In developed Western countries GERD has become the leading gastrointestinal pathology, with the majority of patients requiring long-term treatment. It has been reported that the breakthrough in the incidence of GERD is accompanied by a dramatically decreased prevalence of HP infection and peptic ulcer disease. 2 At the same time, the increase in the incidence of precancerous Barrett s esophagus and esophageal adenocarcinoma has been proven. 3 5 The latter is the one of a few gastrointestinal cancers, the incidence of which is increasing. The negative correlation of these conditions with the prevalence of HP has been reported in some areas and a possible Address correspondence to: Professor Limas Kupcinskas, Chairman of Lithuanian Helicobacter Pylori Study Group, Head of the Department of Gastroenterology, Kaunas University of Medicine, Mickeviciaus 9, 3000 Kaunas, Lithuania. Tel: : Fax: , ; likup@kmu.lt role of HP in protecting against GERD and esophageal adenocarcinoma are proposed, especially stressing the protective role of caga-positive HP strains. 6 8 However there are no evidence-based explanations of this phenomena and further investigations are needed. During the last decade the nosological entity of nonerosive gastroesophageal reflux disease (NERD) has emerged The definition of this disease is still under some discussion, but most have already defined it as severe symptoms of GERD (heartburn and acid regurgitation) significantly interfering with normal daily activity without endoscopically detected erosions in lower esophagus. 12 The pathogenesis of NERD is still not fully understood and some researchers speculate that this condition is a part of non-ulcer dyspepsia and may be related not only to gastroesophageal reflux events, but also to the presence of regulatory abnormalities and HP-induced gastritis There is a lot of discussion regarding whether or not the prevalence of HP is different among erosive versus nonerosive GERD patients and whether or not HP is important in the pathogenesis of the disease The prevalence of HP infection is still high in Eastern European countries, especially in the olderaged population. 19,20 The incidence of GERD is 223

2 224 Diseases of the Esophagus noticeably increasing in this area, although there are no serious epidemiological data confirming it. 21 Therefore we conducted the study of consecutive GERD patients with the aim of finding any differences in demographic and clinical characteristics and in the prevalence of HP between two forms of GERD: erosive esophagitis and NERD. METHODS We investigated 104 consecutive GERD patients (mean age: 41.6 ± 12.3 years) who had not used proton pump inhibitors, bismuth compounds or antibiotics for at least 4 weeks before testing, H 2 -blockers for at least 7 days before testing, antacids for at least 48 h before testing and were not NSAIDs users. We also excluded patients with any severe accompanying diseases. After thorough interviewing of patients using a gastrointestinal symptom rating scale (GSRS) questionnaire a videoendoscopy was performed. During endoscopies, four biopsy specimens from the antrum and four from the corpus were taken for urease testing and histological examination. A single pathologist, who was blinded to any clinical and demographic data, performed histological evaluations of biopsies from the antrum and corpus of the stomach according to the Sydney system. 22 At least 2 h after endoscopy, validated C 14 -urea breath tests (UBT; Heliprobe, Noster System AB, Stockholm) were performed. 23 Helicobacter pylori was investigated using rapid urease test, Giemsa-stained histological specimens and C 14 -UBT. HP positivity established if at least two of these tests were positive. Erosive GERD was defined and evaluated according to the Los-Angeles classification. 24 Non-erosive GERD patients were those who had no erosions in the esophagus (during present investigation and in whom erosions had never been found in the past), but complained of heartburn or/and acid regurgitation at least twice a week with these symptoms having a negative impact on daily activities (Genval consensus). 12 Statistical analysis was performed using SPSS for Windows. The obtained data were analyzed and compared using χ 2 or Student s t-test, and logistic regression. Values of P < 0.05 were considered significant. The study was approved by Ethics Committee of Kaunas University of Medicine. RESULTS Of 104 patients, erosive GERD was found in 53 (51%) patients, (mean age: 41.0 ± 12.7 years) and NERD in 51 (49.0%; mean age: 42.2 ± 11.9 years). In the erosive GERD group there were 27 (50.9%) Fig. 1 Relationship of mean body mass index (BMI) to different degrees of gastroesophageal reflux disease.(nerd, nonerosive GERD.) men and 26 (49.1%) women. In the NERD group there were eight (15.7%) men and 43 (84.3%) women, P < In the erosive GERD group the mean age of men was 35.0 ± 10.2 years, for women it was 47.3 ± 12.1 years, P < In NERD group mean age of the men was 37.7 ± 18.1 years and of women was 43.0 ± 10.4 years, P > According to the Los-Angeles classification in the erosive GERD group there were 21 cases (39.6%) of esophagitis A, 27 cases (50.9%) of esophagitis B, four cases (7.5%) of esophagitis C and one case (1.9%) of esophagitis D. For the convenience of further calculations we joined esophagitis C and D cases into one group the C + D esophagitis group. The mean body mass index (BMI) was ± The mean BMI of erosive GERD patients was ± 4.02 and for NERD patients it was ± 3.99, P > But there were significant differences in mean BMIs between the groups with NERD and esophagitis B, and an obvious trend of higher mean BMIs in patients with esophagitis C + D (significance level not reached due to the small number of patients with severe esophagitis) (Fig. 1). In the erosive GERD group endoscopic hiatus hernia was documented in 48 (90.6%) patients, in the NERD group it was found in 40 patients (78.4%), P = In the esophagitis A group, hernias were found in 16 patients (76.2%); in the esophagitis B group, in 27 patients (100%); and in the esophagitis C + D group in five (100%) patients (according to χ 2 tests, P < 0.05). It is obvious that hiatus hernia is almost always present in severe GERD. In the erosive GERD group there were 18 smokers (34%), in the NERD group there were 10 smokers (19.6%), P = There were six smokers (28.6%) in the esophagitis A group, 10 (37%) in the esophagitis B group and two (40%) in the esophagitis C + D group (according to χ 2 tests, P > 0.05). Frequencies of smokers are nor significantly different, but there is a trend for higher a frequency of smokers in more severe grades of GERD.

3 GERD in high Helicobacter pylori prevalence region 225 Table 1 Mean scores of the histological gastritis characteristics according to Sydney classification in Helicobacter pylori (HP)-positive erosive gastroesophageal reflux disease (GERD) and nonerosive GERD (NERD) patients Antral mucosa Corpus mucosa HP density Gran. Lymph. Atrophy Int. met. HP density Gran. Lymph. Atrophy Int. met. Erosive GERD score (n = 32) ± SD NERD score (n = 41) ± SD P-value NS NS NS 0.04 NS NS NS NS NS NS Gran., granulocytes; Lymph., lymphocytes; Int. met., intestinal metaplasia; NS, not significant. Fig. 2 Helicobacter pylori (HP) prevalence in different grades of gastroesophageal reflux disease (GERD). (NERD, nonerosive GERD.) Altogether HP was established in 73 (70.2%) cases. HP was established in 32 patients (60.4%) in the erosive GERD group and 41 patients (80.4%) in the NERD group, P < Interestingly, male erosive GERD patients were HP-positive in 19 (70.4%) cases and 13 female patients (50%) were HP-positive, P > In contrast, in male NERD patients HP was found less frequently (six cases; 75%) than in women (35 cases; 81.4%), P > There was an obvious trend for lower HP-positivity in the more severe grades of GERD (Fig. 2). We also applied a multivariate analysis model for the prediction of erosive or nonerosive GERD. Logistic regression revealed that there were two statistically significant prediction factors for NERD: female sex with an odds ratio (OR) of 6.34 (95% CI: ), P = and HP infection with an odds ratio (OR) of 3.28 (95% CI: ), P = Smoking status, presence of hiatus hernia and a BMI of more than 24.9 (overweighed persons) did not reach statistical significance in the logistic regression model for prediction of the type of GERD. Based on the GSRS questionnaire we evaluated mean intensity scores of symptoms (epigastric pain, heartburn, acid regurgitation, hunger-like pain, nausea, burping, epigastric fullness, retching, abdominal bloating, constipation, diarrhea, urgency to defecate, incomplete defecation) in erosive GERD and NERD patients. We also evaluated the mean intensity scores of symptoms separately in HP-positive and HPnegative erosive GERD and NERD patients. Only the mean intensity of heartburn was significantly higher among NERD patients (2.92 ± 1.76 vs 3.63 ± 1.27, P = 0.026). We found that the intensity of heartburn remains statistically significantly higher only in HP-positive NERD patients (2.90 ± 1.83 vs 3.68 ± 1.23, P = 0.039). The mean scores of other symptoms were not different between the groups regardless of HP status. The histological characteristics of gastritis of HP-positive erosive and nonerosive GERD patients are presented in the Table 1. There are no significant differences in the gastritis scores in the antrum and corpus of the stomach between erosive GERD and NERD, and there is antrum-predominant gastritis in both erosive and nonerosive GERD patients. Only the mean atrophy score in the antrum was significantly higher (P = 0.04) in the NERD group. Based on endoscopic severity we also divided all GERD cases into mild GERD (NERD and esophagitis A cases) and severe GERD (esophagitis B, C and D). We applied a logistic regression model to find predictors for these two entities. Only two variables were found to be statistically significant predictors for severe GERD absence of HP, with OR 3.99 (95% CI: ), P < 0.01; and male sex, with OR 6.17 (95% CI: ), P < Smoking status, a BMI of more than 24.9 and the presence of hiatus hernia were not significant predictors. DISCUSSION In our consecutive GERD patients series almost half of the patients (49%) were NERD patients, it confirms data from other studies, that this entity accounts for approximately half of all GERD patients and that the patients without erosions are also negatively affected by GERD symptoms and searching medical care. The GSRS-based symptomatic pattern of our NERD patients revealed that their mean heartburn score is (statistically significantly) even higher than that of erosive GERD patients, but this difference was only between HP-infected patients. This could probably be explained by a higher

4 226 Diseases of the Esophagus sensitivity of the lower esophagus, especially if HP is present In a very recent systematic review of 20 studies by Raghunath et al. the prevalence of HP in GERD patients was assessed. 28 There was substantial heterogeneity between studies and this review confirmed that HP is less prevalent in GERD patients especially in Asian countries. There was no data about this topic from Eastern European countries, and our data could be the first published about the prevalence of HP in GERD patients in this geographic area. The overall prevalence of HP in Lithuania is still very high, so it is not surprising for us that HP was found in 70.2% of GERD cases. We found that the prevalence of HP is significantly higher among NERD patients and decreases with the severity of erosive GERD. This supports the theory that HP could be related to GERD, and that the absence of HP may be a risk factor for severe forms of erosive esophagitis, Barrett s esophagus and even esophageal adenocarcinoma. 29,30 In the study by Lagergren et al. it is undoubtedly shown that long-standing GERD is a risk factor for esophageal adenocarcinoma. 31 But it is still not clear which subgroups of GERD patients are at higher risk to esophageal adenocarcinoma probably HP-negative, erosive GERD patients. It is impossible to confirm that the absence of HP (or eradication of HP) is the most important factor for the development of erosive GERD, because a large proportion of erosive GERD patients is also infected by HP in our region. NERD may have significantly different pathogenesis, mainly related to hypersensitivity of the lower esophagus to comparably short-term reflux episodes, which are not able to damage the esophagus. The high proportion of HP-infected NERD patients in our region leads to speculation that this esophageal hypersensitivity may be stimulated by HP-induced inflammatory mediators. Also there still remains the possibility of subjectivity regarding the term heartburn and for the misdiagnosis of NERD. HPpositive patients are more likely to have functional dyspepsia (non-ulcer dyspepsia) and, due to an overlap of symptoms, some purely functional-dyspepsia patients may be regarded as NERD patients. So, it is probably reasonable to separate another group of patients from NERD patients, which could be defined as reflux-like dyspepsia (according to older dyspepsia definition). 32,33 It is well known that smoking status, BMI and the presence of hiatus hernia may be related to more severe GERD Although our data showed obvious trends and differences in these factors between erosive GERD and NERD, multivariate analysis did not show any statistically significant prognostic value. Logistic regression of our data revealed that HP and female sex are statistically significant predictors of NERD. The role of female predisposition to NERD was also stressed by other investigators. 37 We tried to elucidate whether the histological gastritis pattern of HP-infected patients is different between erosive and nonerosive GERD patients. Data have been found that show healing of corpus gastritis may be the main factor in the hypersecretion and development of GERD in the future In our series we found no significant differences in gastritis characteristics. The antrum-predominant gastritis was found in both erosive GERD and NERD patients. Only a higher mean score of atrophy in the antrum was found in erosive GERD patients, but overall atrophy scores were very low, therefore we think this finding is of no importance. So, in our high-hp-prevalent region we are not able to confirm that the type of gastritis is somehow related to erosive esophagitis or NERD. In conclusion, there is a high prevalence of HP infection among GERD patients in the high-hpprevalence region (Lithuania) and we found that the prevalence of HP in NERD patients is statistically higher than in erosive GERD patients. Obvious trends are seen for male sex, decreased prevalence of HP, higher BMI, presence of hiatus hernia with increasing severity of erosive esophagitis, but only HP-positivity and female sex are found to be significant prognostic factors for nonerosive GERD. The exact influence of HP on the pathogenesis of GERD is not known and further studies are needed. References 1 Locke G R, Talley N J, Fett S L, Zinsmeister A R, Melton L J. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county. Minnesota Gastroenterol 1997; 112: El-Serag H B, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: Pera M, Cameron A J, Trastek V F et al. Increasing incidence of adenocarcinoma of esophagus and esophagogastric junction. Gastroenterology 1993; 104: Chow W F L, Blaser M J, Blot W J et al. An inverse correlation between CagA + strains of Helicobacter pylori infection and risk of oesophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: Kocher H M, Linklater K, Patel S, Ellul J P. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg 2001; 88: Loffeld R J, Werdmuller B F, Kuster J G, Pérez-Pérez G I, Blaser M J, Kuipers E J. Colonization with caga-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000; 62: Vicari J J, Peek R M, Falk G W et al. The seroprevalence of caga-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998 July; 115: Fallone C A, Barkun A N, Gottke U M et al. Association of Helicobacter pylori genotypes with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J Gastroenterol 2000; 95: Smout A J P M. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 1997; 11: Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51:

5 GERD in high Helicobacter pylori prevalence region Fass R, Fennerty M B, Vakil N. Nonerosive reflux disease Current concepts and dilemmas. Am J Gastroenterol 2001; 96: Dent J, Brun J, Fendrick A M, Fennerty M B, Janssens J, the Genval Workshop Group. An evidence-based appraisal of reflux disease management. Gut 1998; 44: S1 S Baldi F, Ferrarini F, Longanesi A et al. Acid gastroesophageal reflux and symptom occurrence: Analysis of some factors influencing their association. Dig Dis Sci 1998; 12: O Connor H J. Helicobacter pylori and gastro-oesophageal reflux disease clinical implications and management. Aliment Pharmacol Ther 1999; 13: Manes G, Mosca S, Laccetti M, Lioniello M, Balzano A. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and non-erosive gastroesophageal reflux disease. Scand J Gastroenterol 1999; 34: Fallone C A, Barkun A N, Friedman G, Mayrand S, Loo V, Beech R Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: Labenz J, Blum A L, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology 1997; 112: Vakil N, Kahrilas P, Magner D, Skammer W, Levine J. Does baseline H. pylori status impact erosive esophagitis healing rates? Am J Gastroenterol 2000; 95: Kupcinskas L, Miciulevicienë J. Helicobacter pylori infection in blood donors. Medicina (Kaunas) 1999; 35: Pounder R E. Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9: Bielañski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 1999; 50: Dixon M F, Genta M, Yardley J H, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston Am J Surg Pathol 1996; 20: Hegedus O, Ryden J, Rehnberg A S, Nilsson S, Hellstrom P M. Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis. Eur J Gastroenterol Hepatol 2002; 14: Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999; 72: Rodrigues-Stanley S, Robinson M, Earnest D L, Greenwood van Meerveld B, Miner P B. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: Schmulson M J, Mayer E A. Gastrointestinal sensory abnormalities in functional dyspepsia. Baillieres Clin Gastroenterol 1998; 12: Lundquist P, Seensalu R, Linden B, Nilsson L H, Lindberg H. Symptom criteria do not distinguish between functional and organic dyspepsia. Eur J Surg 1998; 164: Raghunath A, Hungin P S, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: Weston A P, Badr A S, Topalovski M, Cherian R, Dixon A, Hassanein R S. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett s esophagus, Barrett s dysplasia, and Barrett s adenocarcinoma. Am J Gastroenterol 2000; 95: Arents N L, van Zwet A A, Thijs J C, et al. The importance of vaca, caga, and icea genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: Quigley E M M. Non-erosive reflux disease: part of spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001; 13: S13 S Holtmann G, Stanghellini V, Talley N J. Nomenclature of dyspepsia, dyspepsia subgroups, and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol 1998; 12: Stal P, Lindberg G, Ost A, Iwarson M, Seensalu R. Gastroesophageal reflux in healthy subjects. Significance of endoscopic findings, histology, age, and sex. Scand J Gastroenterol 1999; 34: El-Serag H B, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut 1997; 41: Nilsson M, Lundegarth G, Carling L, Ye W, Lagergren J. Body mass and reflux oesophagitis: an oestrogen dependent association? Scand J Gastroenterol 2002; 37: Lind T, Havelund T, Carlsson R et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: Haruma K, Mihara M, Okamoto E et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h ph monitoring. Aliment Pharmacol Ther 1999; 13: Ijima K, Ohara S, Sekine H et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001; 15:

The Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori

The Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori The Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori Maxwell M. Chait The relationship between GERD and H. pylori is complex and negatively associated with important

More information

Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori

Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori 355 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the

More information

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma Characteristics of Characteristics of controls Detection Chow et al (1998) 1993-1995 129 of newly diagnosed oesophageal/gastric cardia (OGC) adenocarcinoma. 224 population controls selected by random digit

More information

Symptoms suggestive of gastroesophageal reflux disease. Gastroesophageal Reflux Among Different Racial Groups in the United States

Symptoms suggestive of gastroesophageal reflux disease. Gastroesophageal Reflux Among Different Racial Groups in the United States GASTROENTEROLOGY 2004;126:1692 1699 Gastroesophageal Reflux Among Different Racial Groups in the United States HASHEM B. EL SERAG,*, NANCY J. PETERSEN, JUNAIA CARTER, DAVID Y. GRAHAM,* PETER RICHARDSON,

More information

Relationship between Esophageal Cardiac Glands and Gastroesophageal Reflux Disease

Relationship between Esophageal Cardiac Glands and Gastroesophageal Reflux Disease ORIGINAL ARTICLE Relationship between Esophageal Cardiac Glands and Gastroesophageal Reflux Disease Kozue Hanada 1, Kyoichi Adachi 1, Tomoko Mishiro 1, Shino Tanaka 1, Yoshiko Takahashi 1, Kazuaki Yoshikawa

More information

Effect of Helicobacter pylori infection and its eradication on nutrition

Effect of Helicobacter pylori infection and its eradication on nutrition Aliment Pharmacol Ther 2002; 16: 799 806. Effect of Helicobacter pylori infection and its eradication on nutrition T. FURUTA*, N. SHIRAI*, F. XIAO*, M. TAKASHIMA* & H. HANAI *First Department of Medicine

More information

Helicobacter pylori Improved Detection of Helicobacter pylori

Helicobacter pylori Improved Detection of Helicobacter pylori DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400

More information

Gastric mucosal status in patients with reflux esophagitis

Gastric mucosal status in patients with reflux esophagitis Gastric mucosal status in patients with reflux esophagitis Riyadh Mohamad Hasan 1, Batool Mutar Mahdi 2 1. Department of Surgery, Al-Kindy College of Medicine, University of Baghdad, Iraq 2. Department

More information

Corpus gastritis is protective against reflux oesophagitis

Corpus gastritis is protective against reflux oesophagitis Gut 1999;45:181 185 181 Corpus is protective against reflux H B El-Serag, A Sonnenberg, M M Jamal, J M Inadomi, L A Crooks, R M Feddersen Department of Veterans AVairs Medical Centre, University of New

More information

Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease

Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease Original Article Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease From Military Hospital, Rawalpindi Obaid Ullah Khan, Abdul Rasheed Correspondence: Dr. Abdul

More information

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment Abstract Objective Design Setting

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment Abstract Objective Design Setting Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment Gianpiero Manes, Antonella Menchise, Claudio de Nucci, Antonio Balzano Abstract Objective

More information

H elicobacter pylori is a human pathogen that causes

H elicobacter pylori is a human pathogen that causes 1543 STOMACH Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects D Vaira, N Vakil, M Rugge, L Gatta, C Ricci, M Menegatti, G Leandro,

More information

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease Gut and Liver, Vol. 8, No. 2, March 2014, pp. 160-164 ORiginal Article The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal

More information

The Impact of Gender on the Symptom Presentation and Life Quality of Patients with Erosive Esophagitis and Non-Erosive Reflux Disease

The Impact of Gender on the Symptom Presentation and Life Quality of Patients with Erosive Esophagitis and Non-Erosive Reflux Disease ARC Journal of Hepatology and Gastroenterology Volume 1, Issue 1, 2016, PP 3-8 www.arcjournals.org The Impact of Gender on the Symptom Presentation and Life Quality of Patients with Erosive Esophagitis

More information

PAPER. Helicobacter pylori Is Not Associated With the Manifestations of Gastroesophageal Reflux Disease

PAPER. Helicobacter pylori Is Not Associated With the Manifestations of Gastroesophageal Reflux Disease PAPER Helicobacter pylori Is Not Associated With the Manifestations of Gastroesophageal Reflux Disease Stefan Öberg, MD; Jeffrey H. Peters, MD; John J. Nigro, MD; Jörg Theisen, MD; Jeffrey A. Hagen, MD;

More information

Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers

Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers doi: 10.2169/internalmedicine.8669-16 Intern Med 56: 2979-2983, 2017 http://internmed.jp ORIGINAL ARTICLE Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux in Healthy Young Japanese

More information

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35. An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology

More information

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb

More information

Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms

Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms nature publishing group ORIGINAL CONTRIBUTIONS 1947 Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms Sui Peng, MD 1, Li-Shou Xiong,

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description

More information

Gastric atrophy: use of OLGA staging system in practice

Gastric atrophy: use of OLGA staging system in practice Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa

More information

Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease

Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease Volume 11 Number 4 2008 VALUE IN HEALTH Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease Ola Junghard, PhD, 1 Ingela Wiklund, PhD

More information

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,

More information

Papers. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Abstract. Methods.

Papers. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Abstract. Methods. Prevalence of Helicobacter pylori in patients with : systematic review Anan Raghunath, A Pali S Hungin, David Wooff, Susan Childs Abstract Objectives To ascertain the prevalence of Helicobacter pylori

More information

Management of dyspepsia and of Helicobacter pylori infection

Management of dyspepsia and of Helicobacter pylori infection Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia

More information

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium

More information

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection

More information

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer 618 University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK K E L McColl A El-Nujumi L S Murray E M El-Omar A Dickson A W Kelman T E Hilditch Correspondence to: Professor

More information

Original Article. Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients

Original Article. Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients Tropical Gastroenterology 2010;31(3):175 179 Original Article Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients Mohsen Amini 1, Ashraf Karbasi 1, Hossein Khedmat 1,

More information

Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing re ux oesophagitis

Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing re ux oesophagitis Aliment Pharmacol Ther 2001; 15: 813±820. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing re ux oesophagitis T. KOIKE, S. OHARA, H. SEKINE, K. IIJIMA,

More information

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3

More information

1. Introduction. Correspondence should be addressed to Wei-Chen Tai; Received 29 May 2013; Accepted 5 July 2013

1. Introduction. Correspondence should be addressed to Wei-Chen Tai; Received 29 May 2013; Accepted 5 July 2013 Gastroenterology Research and Practice Volume 2013, Article ID 480325, 6 pages http://dx.doi.org/10.1155/2013/480325 Clinical Study The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms

More information

Helicobacter pylori Eradication Does Not Exacerbate Reflux Symptoms in Gastroesophageal Reflux Disease

Helicobacter pylori Eradication Does Not Exacerbate Reflux Symptoms in Gastroesophageal Reflux Disease GASTROENTEROLOGY 2001;121:1120 1126 Helicobacter pylori Eradication Does Not Exacerbate Reflux Symptoms in Gastroesophageal Reflux Disease PAUL MOAYYEDI, CHANDU BARDHAN, LYNNE YOUNG, MICHAEL F. DIXON,

More information

Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?

Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17 21 17 Gastroenterology, Hepatology, and Infectious Diseases A Hackelsberger V Schultze G Manes J-E Dominguez-Muñoz P Malfertheiner Pathology, Otto-von-Guericke University, Magdeburg, Germany

More information

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care the ProGERD study

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care the ProGERD study Alimentary Pharmacology and Therapeutics Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care the ProGERD study P. Malfertheiner*, M. Nocon, M. Vieth à, M. Stolte, D.

More information

Role of Corpus Gastritis and caga-positive Helicobacter pylori Infection in Reflux Esophagitis

Role of Corpus Gastritis and caga-positive Helicobacter pylori Infection in Reflux Esophagitis JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2002, p. 2849 2853 Vol. 40, No. 8 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.8.2849 2853.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.

More information

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy

More information

Clinical Profile and Esophagogastroduodenoscopy Finding in Patients with Acid Peptic Disease at a Tertiary Health Care Centre

Clinical Profile and Esophagogastroduodenoscopy Finding in Patients with Acid Peptic Disease at a Tertiary Health Care Centre MVP Journal of Medical Sciences, Vol 4(1), 1 7, January-June 2017 ISSN (Print) : 2348 263X ISSN (Online) : 2348-2648 DOI: 10.18311/mvpjms/2017/v4i1/703 Clinical Profile and Esophagogastroduodenoscopy Finding

More information

Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada

Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon

More information

Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease

Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease Gut and Liver, Vol. 3, No. 4, December 2009, pp. 259-265 original article Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease Jung-Hwan Oh*, Tae-Suk

More information

Introduction. Original articles. Nicolás Rocha, 1 Sandra Huertas, 2 Rosario Albis, 3 Diego Aponte, 4 Luis Carlos Sabbagh. 5

Introduction. Original articles. Nicolás Rocha, 1 Sandra Huertas, 2 Rosario Albis, 3 Diego Aponte, 4 Luis Carlos Sabbagh. 5 Original articles Correlation of endoscopic and histological findings in diagnosis of gastrointestinal metaplasia in patients referred to the Clinica Colombia for upper endoscopies Nicolás Rocha, 1 Sandra

More information

Histological correlates of gastro esophageal reflux disease in South Indian population

Histological correlates of gastro esophageal reflux disease in South Indian population International Journal of Research in Medical Sciences Ramasamy J et al. Int J Res Med Sci. 2016 Jun;4(6):1849-1854 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161441

More information

Non-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics

Non-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics Non-Ulcer : what is it? What can we do with these patients? Temporal Changes and Geographic Variations in Developing Peptic Ulcer Disease Gastric Cancer 1900 Eamonn M M Quigley MD FACG Alimentary Pharmabiotic

More information

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors Aliment Pharmacol Ther 2003; 17 (Suppl. 1): 10 15. Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors J. G. HATLEBAKK Department of Medicine, Haukeland Sykehus,

More information

Post-treatment treatment testing for

Post-treatment treatment testing for Post-treatment treatment testing for Hp eradication should be standard-of-care Neil ilstollman MD, FACG In the old days When treatment regimens were felt to be successful 9+% of the time, routine posttreatment

More information

Keywords: Helicobacter pylori; oesophagitis; gastro-oesophageal reflux disease; atrophic gastritis; gastric cancer

Keywords: Helicobacter pylori; oesophagitis; gastro-oesophageal reflux disease; atrophic gastritis; gastric cancer Gut 2001;49:335 340 335 Division of Gastroenterology, Department of Internal Medicine, University of Tokyo, Tokyo, Japan Y Yamaji M Okamoto H Yoshida T Kawabe Y Shiratori M Omata Department of Gastroenterology,

More information

Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey

Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey Brazilian Journal of Medical and Biological Research (2003) 36: 747-751 Dyspepsia and Helicobacter pylori ISSN 0100-879X 747 Functional dyspepsia: relationship between clinical subgroups and Helicobacter

More information

Comparison of Clinical Findings with Symptom Assessment Systems (GerdQ and FSSG) for Functional Gastrointestinal Diseases

Comparison of Clinical Findings with Symptom Assessment Systems (GerdQ and FSSG) for Functional Gastrointestinal Diseases ORIGINAL PAPER Surg. Gastroenterol. Oncol. 2018;23(3):198-203 DOI: 10.21614/sgo-23-3-198 Comparison of Clinical Findings with Symptom Assessment Systems (GerdQ and FSSG) for Functional Gastrointestinal

More information

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia Gut 2000;46:9 13 9 PAPERS Division of Gastroenterology, University of Kansas, VA Medical Center, Kansas City, Missouri, USA P Sharma A P Weston Department of Pathology, VA Medical Center, Kansas M Topalovski

More information

Gastrointestinal symptoms are still common in a general Western population

Gastrointestinal symptoms are still common in a general Western population ORIGINAL ARTICLE Gastrointestinal are still common in a general Western population L.A.S. van Kerkhoven *, T. Eikendal, R.J.F. Laheij, M.G.H. van Oijen, J.B.M.J. Jansen Department of Gastroenterology &

More information

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine

More information

The Kalixanda Study. Upper GI pathology in the general population

The Kalixanda Study. Upper GI pathology in the general population The Kalixanda Study Upper GI pathology in the general population The Kalixanda Study The project group Lars Agréus, PhD, GP, project leader Pertti Aro, GP Jukka Ronkainen, GP Tom Storskrubb, gastroenterologist

More information

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease 1 Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy; 2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich,

More information

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other Peptic Ulcer Disease and Dyspepsia John M. Inadomi, MD Professor of Medicine UCSF Chief, Clinical Gastroenterology San Francisco General Hospital Case History 49 y/o woman complains of several months of

More information

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja

More information

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease

More information

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia E311 before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Authors Institution Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami,

More information

QUICK QUERIES. Topical Questions, Sound Answers

QUICK QUERIES. Topical Questions, Sound Answers QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University

More information

Barrett s Esophagus: Old Dog, New Tricks

Barrett s Esophagus: Old Dog, New Tricks Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,

More information

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

Pathology of the oesophagus and the stomach. Neil A Shepherd Gloucester, UK. Bristol Pathology 1 st Year Training School, The layers of the GI tract

Pathology of the oesophagus and the stomach. Neil A Shepherd Gloucester, UK. Bristol Pathology 1 st Year Training School, The layers of the GI tract Pathology of the oesophagus and the stomach Neil A Shepherd Gloucester, UK Bristol Pathology 1 st Year Training School, The layers of the GI tract 1 Some facts about Histopathology and the upper GI tract

More information

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus University of Groningen The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus IMPORTANT NOTE: You are advised to consult the publisher's

More information

Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia

Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia Aliment Pharmacol Ther 23; 17: 835 84. doi: 1.146/j.269-2813.23.1497.x Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia A. QUADRI & N. VAKIL University of Wisconsin

More information

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia Gastroenterology Research and Practice Volume 2013, Article ID 184806, 5 pages http://dx.doi.org/10.1155/2013/184806 Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients

More information

ORIGINAL ARTICLE. Abstract. Introduction. Masaki Miyamoto 1, Noriaki Manabe 2 and Ken Haruma 2

ORIGINAL ARTICLE. Abstract. Introduction. Masaki Miyamoto 1, Noriaki Manabe 2 and Ken Haruma 2 ORIGINAL ARTICLE Efficacy of the Addition of Prokinetics for Proton Pump Inhibitor (PPI) Resistant Non-erosive Reflux Disease (NERD) Patients: Significance of Frequency Scale for the Symptom of GERD (FSSG)

More information

Patient-reported Outcomes

Patient-reported Outcomes 3 Patient-reported Outcomes Ingela Wiklund Key points Many gastrointestinal diseases are symptomdriven, so the patient s perspective is particularly important in this area. Patient-reported outcomes (PROs)

More information

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia. INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan

More information

Drug Class Review Proton Pump Inhibitors

Drug Class Review Proton Pump Inhibitors Drug Class Review Proton Pump Inhibitors Evidence Tables April 2009 Update 4: May 2006 Update 3: May 2005 Update 2: April 2004 Update 1: April 2003 Original Report: November 2002 The literature on this

More information

The effect of proton pump inhibitors on the gastric mucosal microenvironment

The effect of proton pump inhibitors on the gastric mucosal microenvironment Original papers The effect of proton pump inhibitors on the gastric mucosal microenvironment Yen-Chun Peng,,, A F, Lan-Ru Huang, A, C, E, Hui-Ching Ho, C, Chi-Sen Chang, C, E, Shou-Wu Lee, E, Ching-Chang

More information

Gastroesophageal reflux disease is a progressive disease

Gastroesophageal reflux disease is a progressive disease Digestive and Liver Disease 39 (2007) 409 414 Viewpoint Gastroesophageal reflux disease is a progressive disease F. Pace a,, S. Pallotta a, N. Vakil b,c a L. Sacco University Hospital, Milan, Italy b University

More information

Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi center Randomized Control Study

Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi center Randomized Control Study Original Article Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi center Randomized Control Study Yan Xue 1, Li Ya Zhou 1, San Ren Lin 1, Xiao Hua Hou 2, Zhao Shen Li 3,

More information

Nimish Vakil 1*, Anna Niklasson 2, Hans Denison 2 and Anna Rydén 2

Nimish Vakil 1*, Anna Niklasson 2, Hans Denison 2 and Anna Rydén 2 Vakil et al. BMC Gastroenterology 2014, 14:177 RESEARCH ARTICLE Open Access Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal

More information

Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication

Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication ORIGINAL ARTICLE Annals of Gastroenterology (2014) 27, 352-356 Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication John M. Moschos a, George Kouklakis

More information

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Alimentary Pharmacology and Therapeutics A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? P. O. Katz*, D. A. Johnson

More information

H Pandya, N Singh, S Singh, P Salvi, J Patel, H Agravat, J Ruparelia

H Pandya, N Singh, S Singh, P Salvi, J Patel, H Agravat, J Ruparelia ISPUB.COM The Internet Journal of Gastroenterology Volume 10 Number 1 Helicobacter Pylori Infection Is Protective Against Development Of Complications Of Gastro Esophageal H Pandya, N Singh, S Singh, P

More information

Unmet Needs in the Management of Gastroesophageal Reflux Disease

Unmet Needs in the Management of Gastroesophageal Reflux Disease Unmet Needs in the Management of Gastroesophageal Reflux Disease Ronnie Fass MD Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal

More information

SUMMARY INTRODUCTION. Accepted for publication 8 July 2004

SUMMARY INTRODUCTION. Accepted for publication 8 July 2004 Aliment Pharmacol Ther 2004; 20: 733 744. doi: 10.1111/j.1365-2036.2004.02172.x Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2016 Next

More information

Committee Approval Date: October 14, 2014 Next Review Date: October 2015

Committee Approval Date: October 14, 2014 Next Review Date: October 2015 Medication Policy Manual Topic: esomeprazole-containing medications: - Nexium - Vimovo - esomeprazole strontium Policy No: dru039 Date of Origin: May 2001 Committee Approval Date: October 14, 2014 Next

More information

Gastroesophageal reflux disease prevalence among school teachers of Saudi Arabia and its impact on their daily life activities

Gastroesophageal reflux disease prevalence among school teachers of Saudi Arabia and its impact on their daily life activities Original Article Gastroesophageal reflux disease prevalence among school teachers of Saudi Arabia and its impact on their daily life activities Abdulrahman Mohammed Altwigry 1, Majed Saud Almutairi 1,

More information

Time Trends of Gastro-esophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) in Iran

Time Trends of Gastro-esophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) in Iran 78 Original Article Time Trends of Gastro-esophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) in Iran SG Sepanlou 1, H Khademi 1, N Abdollahzadeh 1, F Noori 1, F Malekzadeh 1, R Malekzadeh

More information

Functional Dyspepsia. Norbert Welkovics Heine van der Walt

Functional Dyspepsia. Norbert Welkovics Heine van der Walt Norbert Welkovics Heine van der Walt Characteristics: Central abdomen Pain or discomfort Not associated with bowel movements No structural or biochemical abnormalty Definition Part of Gastroduodenal disorders

More information

June By: Reza Gholami

June By: Reza Gholami ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal

More information

GI update. Common conditions and concerns my patients frequently asked about

GI update. Common conditions and concerns my patients frequently asked about GI update Common conditions and concerns my patients frequently asked about Specific conditions I ll try to cover today 1. Colon polyps, colorectal cancer and colonoscopy 2. Crohn s disease 3. Peptic ulcer

More information

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013 MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index

More information

Quality of life in patients with gastroesophageal reflux disease in an Iranian population

Quality of life in patients with gastroesophageal reflux disease in an Iranian population Gastroenterology and Hepatology From Bed to Bench. 2013 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Quality of life in patients with gastroesophageal reflux disease

More information

SUMMARY INTRODUCTION. Aliment Pharmacol Ther 2000; 14: 1595±1603. Accepted for publication 14 August 2000

SUMMARY INTRODUCTION. Aliment Pharmacol Ther 2000; 14: 1595±1603. Accepted for publication 14 August 2000 Aliment Pharmacol Ther 2000; 14: 1595±1603. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal re ux disease (GERD)

More information

The interplay between Helicobacter pylori, gastrooesophageal reflux disease, and intestinal metaplasia

The interplay between Helicobacter pylori, gastrooesophageal reflux disease, and intestinal metaplasia i13 The interplay between Helicobacter pylori, gastrooesophageal reflux disease, and intestinal P Malfertheiner, U Peitz... Helicobacter pylori infection and gastro-oesophageal reflux disease (GERD) account

More information

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 808505, 7 pages http://dx.doi.org/10.1155/2015/808505 Research Article Correlation between Gastric Mucosal Morphologic

More information

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.

More information

Review article: pharmacology of esomeprazole and comparisons with omeprazole

Review article: pharmacology of esomeprazole and comparisons with omeprazole Aliment Pharmacol Ther 2003; 17 (Suppl. 1): 5 9. Review article: pharmacology of esomeprazole and comparisons with omeprazole J. DENT Department of Gastroenterology, Hepatology and General Medicine, Royal

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2016 Next

More information

Functional Heartburn and Dyspepsia

Functional Heartburn and Dyspepsia Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our

More information

Nexium 24HR Pharmacy Training

Nexium 24HR Pharmacy Training Nexium 24HR Pharmacy Training Your pharmacist's advice is required. Always read the label. Use only as directed. If symptoms persist, consult your doctor/ healthcare professional. Pfizer Consumer Healthcare

More information

The phenotype of gastric mucosa coexisting with Barrett s oesophagus

The phenotype of gastric mucosa coexisting with Barrett s oesophagus 456 Department of Oncological and Surgical Sciences, Istochimica e Immunoistochimica Patologica, ULSS 15 del Veneto, Italia M Rugge V Russo G Busatto Departments of Pathology and Medicine, Baylor College

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach

More information